Skip to main content
TipRanks
Go Ultimate75% OFF

Rohto Pharmaceutical Co (RPHCF) Q4 2024 Earnings Report

3 Followers

RPHCF Q4 2024 EPS Results

Actual EPS
$0.17
Consensus EPS
$0.16
Beat/Miss
Beat by +$0.02
One Year Ago EPS
$0.13

RPHCF Q4 2024 Revenue Results

Actual Revenue
$518.84M
Expected Revenue
$545.86M
Beat/Miss
Missed by -$27.02M
YoY Revenue Growth
+18.73%

Earnings Announcement Details

Quarter
Q4 2024
Date
05/13/2025
Time
TBA
Conference Call
Tuesday, May 13, 2025
RPHCF Upcoming Earnings

Rohto Pharmaceutical Co's next earnings date is estimated for February 12, 2027, based on past reporting schedules.

Q4 2024 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2024 Earnings Slide Deck

Q4 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

RPHCF Earnings History

RPHCF earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 12, 20272026 (Q3)0.33-0.29――
Nov 12, 20262026 (Q2)0.200.160.16-0.35% (-0.00)
Aug 06, 20262026 (Q1)0.250.300.33-9.50% (-0.03)
May 13, 20262025 (Q4)0.190.170.17-3.54% (-0.01)
Feb 12, 20262025 (Q3)0.280.290.33-9.71% (-0.03)
Nov 13, 20252025 (Q2)0.160.160.1233.76% (+0.04)
Aug 06, 20252025 (Q1)―0.330.2340.10% (+0.09)
May 13, 20252024 (Q4)0.160.170.1330.69% (+0.04)
Feb 12, 20252024 (Q3)0.310.330.2624.26% (+0.06)
Nov 13, 20242024 (Q2)0.220.120.21-40.83% (-0.08)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed